{"id":"W3036557825","doi":"10.1002/cncr.33036","title":"Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer","year":2020,"lang":"en","type":"article","venue":"Cancer","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Ignyta; Sanofi Genzyme; Genentech; Eisai; Leidos; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Celgene; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Astellas Pharma; Gateway for Cancer Research; Celldex Therapeutics; Pfizer; Kite Pharma; Conquer Cancer Foundation","keywords":"Medicine; HRAS; Internal medicine; Cancer; Prospective cohort study; Oncology; Confidence interval; Salivary gland cancer; Cohort; Gastroenterology; Surgery; Colorectal cancer; KRAS","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001056917,0.0002776884,0.0006564701,0.0002437875,0.0001958233,0.000334299,0.0003132232,0.000245257,0.0007198732],"category_scores_gemma":[0.0007738217,0.00007803732,0.0003895177,0.0003659005,0.0001776287,0.0002108491,0.0002583468,0.0004169704,0.0001563994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005101689,"about_ca_system_score_gemma":0.0005330507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007850563,"about_ca_topic_score_gemma":0.002091621,"domain_scores_codex":[0.9997595,0.0000845363,0.00002795738,0.00003611563,0.00005173453,0.00004007908],"domain_scores_gemma":[0.9995841,0.00008974246,0.0001404471,0.00003592717,0.00004247822,0.0001073116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03022234,0.002325192,0.4808804,0.00122299,0.001137983,0.004244065,0.0004848095,0.003442847,0.05551047,0.000312977,0.005793519,0.4144225],"study_design_scores_gemma":[0.01004939,0.09573625,0.8144651,0.0003281039,0.002006139,0.02069096,0.0004594984,0.006784273,0.03036839,0.0007058589,0.01833891,0.00006706772],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949583,0.003836828,0.0001588397,0.0001283331,0.00001400308,0.00004727798,0.0001457819,0.00002149022,0.0006890599],"genre_scores_gemma":[0.9979856,0.001324838,0.0001984828,0.0001011247,0.0000270509,0.00002680698,0.0002113757,0.000003579674,0.0001211916],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001056917,"threshold_uncertainty_score":0.005589545,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07151105991652265,"score_gpt":0.3514154203827536,"score_spread":0.2799043604662309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}